The Brookdale University Hospital and Medical Center is a nonprofit 501 medical services provider in the borough of Brooklyn, New York City. Brookdale's primary and secondary service areas together comprise 1 million residents. It serves most of Eastern Brooklyn: Brownsville, East New York, Canarsie and East Flatbush.

There are 530 beds in Brookdale University Hospital and Medical Center.

During the past decade, Brookdale University Hospital and Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 11 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brookdale University Hospital and Medical Center" #1 sponsor was "Children's Oncology Group" with 21 trials, followed by "Brookdale University Hospital Medical Center" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brookdale University Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Brookdale University Hospital Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Brookdale University Hospital and Medical Center" are "HIV Infections" (6 trials), "Leukemia" (6 trials), "Sarcoma" (6 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Neuroblastoma" (4 trials). Many other conditions were trialed in "Brookdale University Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "Brookdale University Hospital and Medical Center" are "Drug" (44 trials), "Radiation" (11 trials), "Procedure" (10 trials), "Biological" (9 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "filgrastim" (9 trials), "radiation therapy" (8 trials), "doxorubicin hydrochloride" (6 trials) and "etoposide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Brookdale University Hospital and Medical Center" are 47 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Brookdale University Hospital and Medical Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Brookdale University Hospital and Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brookdale University Hospital and Medical Center, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".